Abstract
Prostate cancer screening often detects indolent cancers - defined as those which would never cause morbidity or mortality if left undetected and untreated. Unnecessary treatment of indolent cancer is a problem associated with this 'overdetection'. Active surveillance is a management strategy for low-risk cancers which can decrease the overtreatment burden.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 124-125 |
| Number of pages | 2 |
| Journal | Nature Reviews Urology |
| Volume | 8 |
| Issue number | 3 |
| DOIs | |
| State | Published - Apr 2011 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Urology
Cite this
Prostate cancer : Reducing overtreatment: Active surveillance in low-risk disease. / Whitson, Jared M; Porten, Sima P.; Carroll, Peter R.
In: Nature Reviews Urology, Vol. 8, No. 3, 04.2011, p. 124-125.Research output: Contribution to journal › Short survey
}
TY - JOUR
T1 - Prostate cancer
T2 - Reducing overtreatment: Active surveillance in low-risk disease
AU - Whitson, Jared M
AU - Porten, Sima P.
AU - Carroll, Peter R.
PY - 2011/4
Y1 - 2011/4
N2 - Prostate cancer screening often detects indolent cancers - defined as those which would never cause morbidity or mortality if left undetected and untreated. Unnecessary treatment of indolent cancer is a problem associated with this 'overdetection'. Active surveillance is a management strategy for low-risk cancers which can decrease the overtreatment burden.
AB - Prostate cancer screening often detects indolent cancers - defined as those which would never cause morbidity or mortality if left undetected and untreated. Unnecessary treatment of indolent cancer is a problem associated with this 'overdetection'. Active surveillance is a management strategy for low-risk cancers which can decrease the overtreatment burden.
UR - http://www.scopus.com/inward/record.url?scp=79952705000&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79952705000&partnerID=8YFLogxK
U2 - 10.1038/nrurol.2011.8
DO - 10.1038/nrurol.2011.8
M3 - Short survey
C2 - 21304508
AN - SCOPUS:79952705000
VL - 8
SP - 124
EP - 125
JO - Nature Reviews Urology
JF - Nature Reviews Urology
SN - 1759-4812
IS - 3
ER -